MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$15,932K
Free Cash flow
-$16,360K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Non-cash operating lease cost
Stock-based compensation expense
Prepaid expenses and other curre...
Others
Negative Cash Flow Breakdown
Net (loss) income
Operating lease liabilities
Accrued expenses and other curre...
Accounts receivable
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Net (accretion) amortization of (discounts) premiums on investments
-
0
-
-
Gain on sale of vowst business, net of transaction costs
-
0
0
-
Amortization of debt issuance costs
-
0
0
0
Net (loss) income
-19,913
-15,335
8,204
12,827
Loss associated with extinguishment of debt
-
0
0
-
(gain)/loss on disposal of fixed assets
-
192
0
0
Impairment of long-lived assets
-
0
0
0
Change in fair value of warrant liabilities
-
0
0
0
Stock-based compensation expense
1,766
3,199
2,482
5,159
Depreciation and amortization expense
781
954
1,044
2,135
Collaboration (profit) loss sharing - related party
-
0
-
-
Non-cash operating lease cost
2,255
2,186
2,125
4,109
Accounts receivable due from spn - related party
-360
-66
-456
-1,186
Accounts receivable
76
-194
351
-
Prepaid expenses and other current and other non-current assets
1,323
19
-688
3,389
Collaboration receivable - related party
-
0
0
0
Inventories
-
0
0
0
Deferred income - related party
-
0
0
0
Deferred revenue - related party
-
0
-
-
Accounts payable
656
5
-515
-1,887
Accrued liabilities due to spn - related party
0
1,172
9,003
4,297
Operating lease liabilities
-2,467
-2,287
-2,181
-4,206
Accrued expenses and other current and long-term liabilities
-1,045
-2,347
633
-4,794
Net cash (used in) provided by operating activities
-16,360
-14,710
2,206
13,621
Purchases of property and equipment
0
29
8
215
Proceeds from sales of property and equipment
-
210
-
-
Purchases of investments
-
0
-
-
Sales and maturities of investments
-
0
-
-
Sales of restricted investments
-
0
0
0
Proceeds from sale of vowst business
-
0
0
-
Net cash (used in) investing activities
0
181
-8
-215
Proceeds from at the market equity offering, net of issuance costs
400
12,171
0
996
Proceeds from exercise of stock options
-
486
15
-
Proceeds from securities purchase agreement - related party
-
0
0
-
Issuance of common stock under espp
28
0
46
184
Proceeds from issuance of debt, net of issuance costs
-
0
-
-
Repayment of notes payable
-
0
0
-
Net cash provided by financing activities
428
12,657
61
1,180
Net (decrease) increase in cash, cash equivalents, and restricted cash
-15,932
-1,872
2,259
14,586
Effect of exchange rate changes on cash, cash equivalents and restricted cash
-
0
-
-
Cash, cash equivalents and restricted cash at beginning of period
54,434
56,306
39,461
-
Cash, cash equivalents and restricted cash at end of period
38,502
54,434
56,306
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from at the
market equity...
$400K
Issuance of common stock
under espp
$28K
Net cash provided by
financing activities
$428K
Net (decrease)
increase in cash, cash...
-$15,932K
Canceled cashflow
$428K
Non-cash operating lease
cost
$2,255K
Stock-based compensation
expense
$1,766K
Prepaid expenses and
other current and...
$1,323K
Depreciation and
amortization expense
$781K
Accounts payable
$656K
Accounts receivable due
from spn - related...
-$360K
Net cash (used in)
provided by operating...
-$16,360K
Canceled cashflow
$7,141K
Net (loss) income
-$19,913K
Operating lease
liabilities
-$2,467K
Accrued expenses and
other current and...
-$1,045K
Accounts receivable
$76K
Buy us a coffee
Seres Therapeutics, Inc. (MCRB)
Seres Therapeutics, Inc. (MCRB)